1. Home
  2. RCAT vs CGEM Comparison

RCAT vs CGEM Comparison

Compare RCAT & CGEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Red Cat Holdings Inc.

RCAT

Red Cat Holdings Inc.

HOLD

Current Price

$8.24

Market Cap

1.1B

Sector

Industrials

ML Signal

HOLD

Logo Cullinan Oncology Inc.

CGEM

Cullinan Oncology Inc.

HOLD

Current Price

$16.25

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RCAT
CGEM
Founded
2002
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Wholesale Distributors
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.1B
IPO Year
2017
2020

Fundamental Metrics

Financial Performance
Metric
RCAT
CGEM
Price
$8.24
$16.25
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
8
Target Price
$20.00
$30.13
AVG Volume (30 Days)
7.0M
548.5K
Earning Date
05-07-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$17,836,382.00
N/A
Revenue This Year
$271.60
N/A
Revenue Next Year
$41.21
$5.20
P/E Ratio
N/A
N/A
Revenue Growth
79.95
N/A
52 Week Low
$5.77
$5.68
52 Week High
$18.78
$19.43

Technical Indicators

Market Signals
Indicator
RCAT
CGEM
Relative Strength Index (RSI) 44.72 43.65
Support Level $7.31 $16.00
Resistance Level $8.85 $19.10
Average True Range (ATR) 0.58 0.95
MACD 0.07 -0.22
Stochastic Oscillator 54.78 16.81

Price Performance

Historical Comparison
RCAT
CGEM

About RCAT Red Cat Holdings Inc.

Red Cat Holdings Inc is a drone technology company integrating robotic hardware and software for military, government, and commercial operations. Its suite of solutions includes the Arachnid family of ISR and precision strike drones, which includes the Black Widow, a small unmanned ISR system; and WEB (Warfighter Electronic Bridge) GCS, designed to command and control an entire drone family of systems for military operations. Its other offerings include Edge 130 Blue drone systems, Trichon, a fixed-wing VTOL for extended endurance and range, and FANG FPV drones optimized for military operations with precision strike capabilities. The firm's Division includes Teal, FlightWave, and Blue Ops.

About CGEM Cullinan Oncology Inc.

Cullinan Therapeutics Inc is a clinical-stage biopharmaceutical company developing therapies for autoimmune diseases and cancer. Its development pipeline comprises the following drug candidates: CLN-978, a CD19xCD3 bispecific T cell engager that is being developed for autoimmune diseases; CLN-049, a FLT3xCD3 bispecific T cell engager being evaluated in an ongoing clinical trial in patients with relapsed/refractory acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS); Velinotamig, a BCMAxCD3 bispecific T cell engager being developed to counter autoimmune diseases; and Zipalertinib, being developed as a treatment for non-small cell lung cancer. Additionally, the company is developing several preclinical programs in autoimmune diseases and oncology.

Share on Social Networks: